Digital Community to Improve Health in Rural Areas
The study is a cluster randomized controlled trial developed in counties located in Appalachia and the Midwest. We will prioritize counties from states with high risk for HIV and HCV infection associated with injection drug use.
Conditions:
🦠 HIV Infections 🦠 Hepatitis C Virus Infection
🗓️ Study Start (Actual) 12 June 2023
🗓️ Primary Completion (Estimated) 30 December 2024
✅ Study Completion (Estimated) 30 December 2024
👥 Enrollment (Estimated) 600
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Philadelphia, Pennsylvania, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Lives in target zip codes
    • * Half not using illicit substances (not including marijuana) currently or in the past
    • * Half using illicit substances (not including marijuana) currently or in the past

    Exclusion Criteria:

    • * Under the age of 18
    • * Not in target zip codes
Ages Eligible for Study: 18 Years to 99 Years (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 21 April 2022
  • First Submitted that Met QC Criteria 2 May 2022
  • First Posted 6 May 2022

Study Record Updates

  • Last Update Submitted that Met QC Criteria 10 June 2024
  • Last Update Posted 12 June 2024
  • Last Verified June 2024